| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Allogeneic Immunotherapy for Malignant Diseases. J. Barrett & Y. Z. Jiang (eds). Marcel Dekker, New York/Basel, January 2000, 408 pp, ill., 165.00.
|
P. H. M. de Mulder
|
|
2001
|
12 |
5 |
p. 726-726
1 p.
|
artikel
|
| 2 |
A phase I and pharmacologic study of capecitabine and paclitaxel in breast cancer patients
|
M. A. Villalona-Calero
|
|
2001
|
12 |
5 |
p. 605-614
10 p.
|
artikel
|
| 3 |
A pilot study of chronomodulated infusional 5-fluorouracil chemoradiation for pancreatic cancer
|
D. R. Penberthy
|
|
2001
|
12 |
5 |
p. 681-684
4 p.
|
artikel
|
| 4 |
Bone scan had no role in the staging of 765 consecutive operable T12N01 breast cancer patients without skeletal symptoms
|
G. Curigliano
|
|
2001
|
12 |
5 |
p. 724-725
2 p.
|
artikel
|
| 5 |
Cheap drugs? Part 3: Bush continues Clinton policy on AIDS drugs but...;All is not well in Frances medical research;Even in Switzerland... the cowboy strikes again;Italian expert committee reports on uranium waste... and the wastebasket is already full of newspapers;Cheap drugs? Part 4: Blair sides with industry or simply protects intellectual property?;European Council moves to encourage research;The virtual supercomputer: Science-fiction becomes a reality against cancer;Perhaps not everyone knows that...
|
|
|
2001
|
12 |
5 |
p. 577-581
5 p.
|
artikel
|
| 6 |
Coronary spasm induced by capecitabine
|
B. Schnetzler
|
|
2001
|
12 |
5 |
p. 723-724
2 p.
|
artikel
|
| 7 |
Estrogen-receptor-directed neoadjuvant therapy for breast cancer: Results of a randomised trial using formestane and methotrexate, mitozantrone and mitomycin C (MMM) chemotherapy
|
J.-C. Gazet
|
|
2001
|
12 |
5 |
p. 685-691
7 p.
|
artikel
|
| 8 |
Evaluation of HER2, p53, bcl-2, topoisomerase II-, heat shock proteins 27 and 70 in primary breast cancer and metastatic ipsilateral axillary lymph nodes
|
F. Cardoso
|
|
2001
|
12 |
5 |
p. 615-620
6 p.
|
artikel
|
| 9 |
High-dose chemotherapy for ovarian cancer: Are we ready to go?
|
S. Aebi
|
|
2001
|
12 |
5 |
p. 583-584
2 p.
|
artikel
|
| 10 |
High-dose chemotherapy for ovarian carcinoma: Long-term results from the Solid Tumour Registry of the European Group for Blood and Marrow Transplantation (EBMT)
|
J. A. Ledermann
|
|
2001
|
12 |
5 |
p. 693-699
7 p.
|
artikel
|
| 11 |
Paclitaxel: Epirubicin in metastatic breast cancer a review
|
E. D. Razis
|
|
2001
|
12 |
5 |
p. 593-598
6 p.
|
artikel
|
| 12 |
Phase I and pharmacokinetic study of hepatic arterial infusion with oxaliplatin in combination with folinic acid and 5-fluorouracil in patients with hepatic metastases from colorectal cancer
|
W. Kern
|
|
2001
|
12 |
5 |
p. 599-603
5 p.
|
artikel
|
| 13 |
Phase II trial of bimonthly leucovorin, 5-fluorouracil and gemcitabine for advanced pancreatic adenocarcinoma (FOLFUGEM)
|
C. Louvet
|
|
2001
|
12 |
5 |
p. 675-679
5 p.
|
artikel
|
| 14 |
Phase I study of a weekly schedule of oxaliplatin, high-dose leucovorin, and infusional fluorouracil in pretreated patients with advanced colorectal cancer
|
G. Rosati
|
|
2001
|
12 |
5 |
p. 669-674
6 p.
|
artikel
|
| 15 |
Phase I study of BBR 2778, a new aza-anthracenedione, in advanced or refractory non-Hodgkins lymphoma
|
P. Borchmann
|
|
2001
|
12 |
5 |
p. 661-667
7 p.
|
artikel
|
| 16 |
Phase I trial of gemcitabine and CPT-11 given weekly for four weeks every six weeks
|
S. R. Alberts
|
|
2001
|
12 |
5 |
p. 627-631
5 p.
|
artikel
|
| 17 |
Phase I trial of sequential administration of raltitrexed (Tomudex) and 5-iodo-2′-deoxyuridine (IdUrd)
|
E. Galanis
|
|
2001
|
12 |
5 |
p. 701-707
7 p.
|
artikel
|
| 18 |
Phase I trial of simultaneously administered GM-CSF and IL-6 in patients with renal-cell carcinoma: Clinical and laboratory effects
|
J. Tate
|
|
2001
|
12 |
5 |
p. 655-659
5 p.
|
artikel
|
| 19 |
Pitfalls in imaging Hodgkins disease with computed tomography and positron emission tomography using fluorine-18-fluorodeoxyglucose
|
M. Sandherr
|
|
2001
|
12 |
5 |
p. 719-722
4 p.
|
artikel
|
| 20 |
P. Vaupel, D. K. Kelleher (eds): Tumor Hypoxia Pathophysiology, Clinical Significance and Therapeutic Perspectives
|
A. L. Harris
|
|
2001
|
12 |
5 |
p. 582-582
1 p.
|
artikel
|
| 21 |
Rectal metastases from lobular carcinoma of the breast: Report of a case and literature review
|
A. Bamias
|
|
2001
|
12 |
5 |
p. 715-718
4 p.
|
artikel
|
| 22 |
Retrospective study of the prognostic role of serum thymidine kinase level in CLL patients with active disease treated with fludarabine
|
F. Di Raimondo
|
|
2001
|
12 |
5 |
p. 621-625
5 p.
|
artikel
|
| 23 |
Risk assessment in ALL in children: A focus on PCR-based techniques for MRD detection
|
V. de Haas
|
|
2001
|
12 |
5 |
p. 587-592
6 p.
|
artikel
|
| 24 |
Second-line treatment with oxaliplatin + raltitrexed in patients with advanced colorectal cancer failing fluoropyrimidine/leucovorin-based chemotherapy
|
W. Scheithauer
|
|
2001
|
12 |
5 |
p. 709-714
6 p.
|
artikel
|
| 25 |
Superiority of high-dose platinum (cisplatin and carboplatin) compared to carboplatin alone in combination chemotherapy for small-cell lung carcinoma: A prospective randomised trial of 280 consecutive patients
|
F. R. Hirsch
|
|
2001
|
12 |
5 |
p. 647-653
7 p.
|
artikel
|
| 26 |
Systematic esophageal endoscopy screening in patients previously treated for head and neck squamous-cell carcinoma
|
T. Petit
|
|
2001
|
12 |
5 |
p. 643-646
4 p.
|
artikel
|
| 27 |
The impact of docetaxel, estramustine, and low dose hydrocortisone on the quality of life of men with hormone refractory prostate cancer and their partners: A feasibility study
|
A. B. Kornblith
|
|
2001
|
12 |
5 |
p. 633-641
9 p.
|
artikel
|
| 28 |
The role of cisplatin in the treatment of small-cell lung cancer?
|
T. Berghmans
|
|
2001
|
12 |
5 |
p. 585-586
2 p.
|
artikel
|
| 29 |
Will the sentinel lymph node (SLN) stand a second time SLN biopsy in breast cancer patients with isolated local recurrence following breast conserving therapy and previous SLN procedure
|
J. gajnar
|
|
2001
|
12 |
5 |
p. 723-723
1 p.
|
artikel
|
Tijdschrift beschrijving